MSACL 2018 US Abstract Title: Obtaining FDA Clearance via the de novo Pathway, for the First IVD LC-MS/MS 25-Hydroxyvitamin D Assay Michal Weinstock SCIEX
Description
Y/N
Source
Grants
no
Salary
no
Board Member
no
Stock
no
Expenses
no
IP Royalty: no
Planning to mention or discuss specific products or technology of the company(ies) listed above: